Who has invested in Alentis Therapeutics?

OrbiMed, Novo Holdings, Jeito Capital, Frazier Life Sciences, Longitude Capital, Catalio Capital are named among the investors backing Alentis Therapeutics.

Alentis Therapeutics Funding: $366M Raised, Series D (2024)

Alentis Therapeutics funding overview

Alentis Therapeutics is based in Basel, Switzerland. Alentis Therapeutics has raised $366M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in November 2024. The round record for Alentis Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include OrbiMed, Novo Holdings, Jeito Capital, Frazier Life Sciences, Longitude Capital, Catalio Capital and 6 others. 12 distinct backers are named across the disclosed rounds.

Alentis Therapeutics at a glance

Total raised: $366M
Latest round: Series D
Latest round date: November 2024
Headquarters: Basel, Switzerland
Notable investors: OrbiMed, Novo Holdings, Jeito Capital, Frazier Life Sciences, Longitude Capital, Catalio Capital, Piper Heartland Healthcare Capital, Avego Bioscience Capital

Frequently asked about Alentis Therapeutics funding

How much has Alentis Therapeutics raised?: Alentis Therapeutics has raised $366M in total disclosed funding across the rounds on record.
Who has invested in Alentis Therapeutics?: OrbiMed, Novo Holdings, Jeito Capital, Frazier Life Sciences, Longitude Capital, Catalio Capital are named among the investors backing Alentis Therapeutics.
What was the latest Alentis Therapeutics funding round?: The most recent disclosed round is a Series D, announced in November 2024.
Where is Alentis Therapeutics based?: Alentis Therapeutics is based in Basel, Switzerland.
When did Alentis Therapeutics last raise?: The last disclosed Alentis Therapeutics round closed in November 2024 at Series D.

Every Alentis Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Basel at a similar stage.

Alentis Therapeutics Funding: $366M Raised, Series D (2024)

Alentis Therapeutics funding overview

Alentis Therapeutics at a glance

Frequently asked about Alentis Therapeutics funding

Companies related to Alentis Therapeutics (35)

Browse related funding lists (7)